These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10192656)

  • 1. The effects of oestrogen replacement therapy on haemostatic variables in postmenopausal women with non-insulin-dependent diabetes mellitus.
    Hahn L; Mattsson LA; Andersson B; Tengborn L
    Blood Coagul Fibrinolysis; 1999 Mar; 10(2):81-6. PubMed ID: 10192656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of 17 beta-oestradiol on variables of coagulation and fibrinolysis in postmenopausal women with type 2 diabetes mellitus.
    Brussaard HE; Leuven JA; Krans HM; Kluft C
    Vascul Pharmacol; 2002 Aug; 39(3):141-7. PubMed ID: 12616982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial.
    Scarabin PY; Alhenc-Gelas M; Plu-Bureau G; Taisne P; Agher R; Aiach M
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3071-8. PubMed ID: 9409295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM.
    Brussaard HE; Gevers Leuven JA; Frölich M; Kluft C; Krans HM
    Diabetologia; 1997 Jul; 40(7):843-9. PubMed ID: 9243107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulin-dependent diabetes mellitus.
    Andersson B; Mattsson LA; Hahn L; Mårin P; Lapidus L; Holm G; Bengtsson BA; Björntorp P
    J Clin Endocrinol Metab; 1997 Feb; 82(2):638-43. PubMed ID: 9024268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of continuous combined HRT on glucose homeostasis and plasma lipids. A placebo-controlled study in postmenopausal women with type 2 diabetes.
    Thunell L; Andersson B; Glassell M; Mattsson LA
    Maturitas; 2006 Mar; 53(4):430-8. PubMed ID: 16198072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of transdermal estradiol in combination with oral norethisterone on lipoproteins, coagulation, and endothelial markers in postmenopausal women with type 2 diabetes: a randomized, placebo-controlled study.
    Perera M; Sattar N; Petrie JR; Hillier C; Small M; Connell JM; Lowe GD; Lumsden MA
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1140-3. PubMed ID: 11238498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemostatic activation in post-menopausal women taking low-dose hormone therapy: less effect with transdermal administration?
    Brosnan JF; Sheppard BL; Norris LA
    Thromb Haemost; 2007 Apr; 97(4):558-65. PubMed ID: 17393018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of low-dose oral and transdermal estrogen replacement therapy on hemostatic factors in healthy postmenopausal women: a randomized placebo-controlled study.
    Post MS; van der Mooren MJ; van Baal WM; Blankenstein MA; Merkus HM; Kroeks MV; Franke HR; Kenemans P; Stehouwer CD
    Am J Obstet Gynecol; 2003 Nov; 189(5):1221-7. PubMed ID: 14634544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, placebo-controlled trial of the effects of continuous combined hormone replacement therapy on coagulation and fibrinolytic systems in healthy postmenopausal women.
    Salobir BG; Keber I; Vrabic L
    Fertil Steril; 2002 Dec; 78(6):1178-83. PubMed ID: 12477508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of heparin treatment on hemostatic abnormalities in obese non-insulin-dependent diabetic patients.
    Avellone G; di Garbo V; Cordova R; Rotolo G; Raneli G; de Simone R; Bompiani G
    Metabolism; 1997 Aug; 46(8):930-4. PubMed ID: 9258277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of transdermal oestradiol and oral progestogens on haemostasis variables.
    Kroon UB; Tengborn L; Rita H; Bäckström AC
    Br J Obstet Gynaecol; 1997 Nov; 104 Suppl 16():32-7. PubMed ID: 9389781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of two different types of hormone therapy effects on haemostatic parameters in early postmenopausal women].
    Tasić L; Dunjić R; Vasiljević M; Dikić S; Jurisić A; Tasić D
    Srp Arh Celok Lek; 2011; 139(1-2):52-7. PubMed ID: 21568083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis.
    Teede HJ; McGrath BP; Smolich JJ; Malan E; Kotsopoulos D; Liang YL; Peverill RE
    Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1404-9. PubMed ID: 10807761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy and hemostasis: effects in Brazilian postmenopausal women.
    Callejon DR; Franceschini SA; Montes MB; Toloi MR
    Maturitas; 2005; 52(3-4):249-55. PubMed ID: 16257613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial of effect of transdermal continuous combined hormone replacement therapy on cardiovascular risk markers.
    Stevenson JC; Oladipo A; Manassiev N; Whitehead MI; Guilford S; Proudler AJ
    Br J Haematol; 2004 Mar; 124(6):802-8. PubMed ID: 15009069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial.
    Kanaya AM; Herrington D; Vittinghoff E; Lin F; Grady D; Bittner V; Cauley JA; Barrett-Connor E;
    Ann Intern Med; 2003 Jan; 138(1):1-9. PubMed ID: 12513038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinolytic potential is significantly increased by oestrogen treatment in postmenopausal women with mild dyslipidaemia.
    Gebara OC; Mittleman MA; Walsh BW; Lipinska I; Welty FK; Bellotti G; Muller JE; Sacks FK; Tofler GH
    Heart; 1998 Sep; 80(3):235-9. PubMed ID: 9875081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.